Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Combination of 4-hydroxyandrostenedione, Serenoa serrulata fruit extract and alpha lipoic acid

EU orphan designation number: EU/3/16/1646   
Active ingredient: Combination of 4-hydroxyandrostenedione, Serenoa serrulata fruit extract and alpha lipoic acid
Indication: Treatment of multiple symmetric lipomatosis
Sponsor: Dr Regenold GmbH
Zöllinplatz 4, 79410 Badenweiler, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/05/2016 Orphan designation EMA/OD/251/15 (2016) 2723 of 28/04/2016
7/07/2017 Change of name and/or address of sponsor